APOE and Alzheimer disease: Due to a selection process that targeted cases with minimal risk as predicted by known risk factors (age, sex and APOE genotype) and targeted controls with the least probability of conversion to AD by age 85 years16, only APOE ε3ε3 cases and controls were well matched with respect to age and sex (Methods).